Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1898 1
2003 2
2004 1
2005 1
2006 2
2007 2
2009 5
2010 3
2011 4
2012 3
2013 10
2014 7
2015 5
2016 13
2017 12
2018 12
2019 16
2020 21
2021 19
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

130 results
Results by year
Filters applied: . Clear all
Page 1
Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers.
Naidoo J, Schreck KC, Fu W, Hu C, Carvajal-Gonzalez A, Connolly RM, Santa-Maria CA, Lipson EJ, Holdhoff M, Forde PM, Douville C, Riemer J, Barnes A, Redmond KJ, Kleinberg L, Page B, Aygun N, Kinzler KW, Papadopoulos N, Bettegowda C, Venkatesan A, Brahmer JR, Grossman SA. Naidoo J, et al. Among authors: connolly rm. J Immunother Cancer. 2021 Aug;9(8):e002473. doi: 10.1136/jitc-2021-002473. J Immunother Cancer. 2021. PMID: 34380662 Free PMC article.
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group.
Connolly RM, Zhao F, Miller KD, Lee MJ, Piekarz RL, Smith KL, Brown-Glaberman UA, Winn JS, Faller BA, Onitilo AA, Burkard ME, Budd GT, Levine EG, Royce ME, Kaufman PA, Thomas A, Trepel JB, Wolff AC, Sparano JA. Connolly RM, et al. J Clin Oncol. 2021 Oct 1;39(28):3171-3181. doi: 10.1200/JCO.21.00944. Epub 2021 Aug 6. J Clin Oncol. 2021. PMID: 34357781 Clinical Trial.
TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
Freedman RA, Gelman RS, Anders CK, Melisko ME, Parsons HA, Cropp AM, Silvestri K, Cotter CM, Componeschi KP, Marte JM, Connolly RM, Moy B, Van Poznak CH, Blackwell KL, Puhalla SL, Jankowitz RC, Smith KL, Ibrahim N, Moynihan TJ, O'Sullivan CC, Nangia J, Niravath P, Tung N, Pohlmann PR, Burns R, Rimawi MF, Krop IE, Wolff AC, Winer EP, Lin NU; Translational Breast Cancer Research Consortium. Freedman RA, et al. Among authors: connolly rm. J Clin Oncol. 2019 May 1;37(13):1081-1089. doi: 10.1200/JCO.18.01511. Epub 2019 Mar 12. J Clin Oncol. 2019. PMID: 30860945 Free PMC article. Clinical Trial.
The future of Blue Carbon science.
Macreadie PI, Anton A, Raven JA, Beaumont N, Connolly RM, Friess DA, Kelleway JJ, Kennedy H, Kuwae T, Lavery PS, Lovelock CE, Smale DA, Apostolaki ET, Atwood TB, Baldock J, Bianchi TS, Chmura GL, Eyre BD, Fourqurean JW, Hall-Spencer JM, Huxham M, Hendriks IE, Krause-Jensen D, Laffoley D, Luisetti T, Marbà N, Masque P, McGlathery KJ, Megonigal JP, Murdiyarso D, Russell BD, Santos R, Serrano O, Silliman BR, Watanabe K, Duarte CM. Macreadie PI, et al. Among authors: connolly rm. Nat Commun. 2019 Sep 5;10(1):3998. doi: 10.1038/s41467-019-11693-w. Nat Commun. 2019. PMID: 31488846 Free PMC article. Review.
COVID-19 recovery can benefit biodiversity.
Pearson RM, Sievers M, McClure EC, Turschwell MP, Connolly RM. Pearson RM, et al. Among authors: connolly rm. Science. 2020 May 22;368(6493):838-839. doi: 10.1126/science.abc1430. Science. 2020. PMID: 32439784 No abstract available.
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609).
Adams S, Othus M, Patel SP, Miller KD, Chugh R, Schuetze SM, Chamberlin MD, Haley BJ, Storniolo AMV, Reddy MP, Anderson SA, Zimmerman CT, O'Dea AP, Mirshahidi HR, Ahnert JR, Brescia FJ, Hahn O, Raymond JM, Biggs DD, Connolly RM, Sharon E, Korde LA, Gray RJ, Mayerson E, Plets M, Blanke CD, Chae YK, Kurzrock R. Adams S, et al. Among authors: connolly rm. Clin Cancer Res. 2022 Jan 15;28(2):271-278. doi: 10.1158/1078-0432.CCR-21-2182. Epub 2021 Oct 29. Clin Cancer Res. 2022. PMID: 34716198 Free PMC article. Clinical Trial.
Fisheries rely on threatened salt marshes.
Baker R, Taylor MD, Able KW, Beck MW, Cebrian J, Colombano DD, Connolly RM, Currin C, Deegan LA, Feller IC, Gilby BL, Kimball ME, Minello TJ, Rozas LP, Simenstad C, Turner RE, Waltham NJ, Weinstein MP, Ziegler SL, Zu Ermgassen PSE, Alcott C, Alford SB, Barbeau MA, Crosby SC, Dodds K, Frank A, Goeke J, Goodridge Gaines LA, Hardcastle FE, Henderson CJ, James WR, Kenworthy MD, Lesser J, Mallick D, Martin CW, McDonald AE, McLuckie C, Morrison BH, Nelson JA, Norris GS, Ollerhead J, Pahl JW, Ramsden S, Rehage JS, Reinhardt JF, Rezek RJ, Risse LM, Smith JAM, Sparks EL, Staver LW. Baker R, et al. Among authors: connolly rm. Science. 2020 Nov 6;370(6517):670-671. doi: 10.1126/science.abe9332. Science. 2020. PMID: 33154131 No abstract available.
Automatic detection of fish and tracking of movement for ecology.
Lopez-Marcano S, L Jinks E, Buelow CA, Brown CJ, Wang D, Kusy B, M Ditria E, Connolly RM. Lopez-Marcano S, et al. Among authors: connolly rm. Ecol Evol. 2021 May 18;11(12):8254-8263. doi: 10.1002/ece3.7656. eCollection 2021 Jun. Ecol Evol. 2021. PMID: 34188884 Free PMC article.
Global trends in mangrove forest fragmentation.
Bryan-Brown DN, Connolly RM, Richards DR, Adame F, Friess DA, Brown CJ. Bryan-Brown DN, et al. Among authors: connolly rm. Sci Rep. 2020 Apr 28;10(1):7117. doi: 10.1038/s41598-020-63880-1. Sci Rep. 2020. PMID: 32346000 Free PMC article.
130 results